AR064869A1 - Uso e un compuesto de formula i- composicion farmaceutica- metodo de tratamiento - Google Patents
Uso e un compuesto de formula i- composicion farmaceutica- metodo de tratamientoInfo
- Publication number
- AR064869A1 AR064869A1 ARP080100134A ARP080100134A AR064869A1 AR 064869 A1 AR064869 A1 AR 064869A1 AR P080100134 A ARP080100134 A AR P080100134A AR P080100134 A ARP080100134 A AR P080100134A AR 064869 A1 AR064869 A1 AR 064869A1
- Authority
- AR
- Argentina
- Prior art keywords
- halogen
- alkyl
- refers
- term
- group
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Uso de un compuesto de formula 1:donde R1, R2 y R3 son iguales o diferentes y significan hidrogenos, halogenos, alquilo, alquilarilo, alquiloxi, hidroxi, nitro, amino, alquilcarbonilamino, alquilamino o grupo dialquilamino; R4 significa hidrogeno, alquilo o grupo alquilarilo; X significa CH2, átomo de oxígeno o átomo de azufre; n es 1, 2 o 3, con la condicion de que cuando n es 1, X no es CH2 y los enantiomeros individuales (R)- y (S)- o mezclas de enantiomeros y sales farmacéuticarnente aceptables de los mismos; donde el término alquilo se refiere a cadenas hidrocarbonadas, rectas o ramificadas, que contienen desde uno a seis átomos de carbono, opcionalmente sustituido con grupos arilo, alcoxi, halogeno, alcoxicarbonilo o hidroxicarbonilo; el término arilo se refiere a un grupo fenilo o naftilo, opcionalmente sustituido con un grupo alquiloxi, halogeno o nitro; el término halogeno se refiere a fluor, cloro, bromo o yodo, en la fabricacion de un medicamento para el tratamiento de una o más de las siguientes afecciones:insuficiencia cardíaca congestiva, angina, arritmias, trastornos de la circulacion tales como Fenomeno de Raynaud, migrana, y trastornos de la ansiedad.composicion farmaceutica, metodo de tratamiento.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0700635.6A GB0700635D0 (en) | 2007-01-12 | 2007-01-12 | Therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR064869A1 true AR064869A1 (es) | 2009-04-29 |
Family
ID=37809883
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP080100134A AR064869A1 (es) | 2007-01-12 | 2008-01-11 | Uso e un compuesto de formula i- composicion farmaceutica- metodo de tratamiento |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20100286219A1 (es) |
| EP (1) | EP2111262A2 (es) |
| JP (1) | JP2010515726A (es) |
| KR (1) | KR20090100443A (es) |
| CN (1) | CN101600474A (es) |
| AR (1) | AR064869A1 (es) |
| AU (1) | AU2008204006A1 (es) |
| BR (1) | BRPI0806514A2 (es) |
| CA (1) | CA2674305A1 (es) |
| GB (1) | GB0700635D0 (es) |
| MX (1) | MX2009007329A (es) |
| RU (1) | RU2009130726A (es) |
| WO (1) | WO2008085074A2 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102259938B1 (ko) | 2012-11-14 | 2021-06-03 | 바이알 - 포르텔라 앤드 씨에이 에스에이 | 폐동맥 고혈압 및 폐 손상의 치료에 이용하기 위한 1,3-디히드로이미다졸-2-티온 유도체 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7125904B2 (en) * | 2002-10-11 | 2006-10-24 | Portela & C.A., S.A. | Peripherally-selective inhibitors of dopamine-β-hydroxylase and method of their preparation |
-
2007
- 2007-01-12 GB GBGB0700635.6A patent/GB0700635D0/en not_active Ceased
-
2008
- 2008-01-10 EP EP08705171A patent/EP2111262A2/en not_active Withdrawn
- 2008-01-10 CN CNA2008800020370A patent/CN101600474A/zh active Pending
- 2008-01-10 MX MX2009007329A patent/MX2009007329A/es not_active Application Discontinuation
- 2008-01-10 CA CA002674305A patent/CA2674305A1/en not_active Abandoned
- 2008-01-10 US US12/522,525 patent/US20100286219A1/en not_active Abandoned
- 2008-01-10 WO PCT/PT2008/000001 patent/WO2008085074A2/en active Application Filing
- 2008-01-10 RU RU2009130726/15A patent/RU2009130726A/ru unknown
- 2008-01-10 BR BRPI0806514-4A patent/BRPI0806514A2/pt not_active IP Right Cessation
- 2008-01-10 JP JP2009545511A patent/JP2010515726A/ja active Pending
- 2008-01-10 AU AU2008204006A patent/AU2008204006A1/en not_active Abandoned
- 2008-01-10 KR KR1020097016624A patent/KR20090100443A/ko not_active Application Discontinuation
- 2008-01-11 AR ARP080100134A patent/AR064869A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2010515726A (ja) | 2010-05-13 |
| CN101600474A (zh) | 2009-12-09 |
| WO2008085074A3 (en) | 2008-12-11 |
| MX2009007329A (es) | 2009-07-15 |
| CA2674305A1 (en) | 2008-07-17 |
| AU2008204006A1 (en) | 2008-07-17 |
| AU2008204006A8 (en) | 2009-08-27 |
| WO2008085074A2 (en) | 2008-07-17 |
| US20100286219A1 (en) | 2010-11-11 |
| WO2008085074A8 (en) | 2009-01-29 |
| EP2111262A2 (en) | 2009-10-28 |
| RU2009130726A (ru) | 2011-02-20 |
| BRPI0806514A2 (pt) | 2011-09-13 |
| GB0700635D0 (en) | 2007-02-21 |
| KR20090100443A (ko) | 2009-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR112789A2 (es) | COMPUESTOS INHIBIDORES DE DOPAMINA-b-HIDROXILASA | |
| AR038419A1 (es) | Derivados de piridina y quinolina | |
| AR075583A1 (es) | Derivados de isoxazol/o-piridina con eslabon etilo o etenilo | |
| PE20141726A1 (es) | Heterociclilaminas como inhibidores de pi 3k | |
| CR20110013A (es) | Derivados de Heteroarilo como Inhibidores de DGAT1 | |
| AR083542A1 (es) | Piperidin-4-il-azetidin diamidas como inhibidores de monoacilglicerol lipasa | |
| CO6400194A2 (es) | Nuevas bencesulfonamidas como bloqueadores de canales de calcio | |
| PE20142282A1 (es) | Nuevos derivados de aril-quinolina | |
| AR060595A1 (es) | Un proceso para preparar derivados enantiomericos de dibenz[b,f]-azepina | |
| AR084011A1 (es) | Compuestos nitrogenados heterociclicos utiles para el tratamiento de infecciones por el virus sincitial respiratorio (rsv), proceso para prepararlos y composiciones farmaceuticas que los contienen | |
| PE20140968A1 (es) | Derivados de benzamida sustituida | |
| CR10671A (es) | Compuestos azabiciclicos como inhibidores de la recaptacion de monoaminas | |
| CO6260069A2 (es) | Tiazolopiridin-2-iloxi-fenil y tiazolopirazin-2-iloxi-fenil aminas como moduladores de la leucotrieno a4 hidrolasa | |
| AR072510A1 (es) | Derivados de triazinas y de uracilos, su preparacion y su aplicacion en terapeutica humana | |
| AR081893A1 (es) | Derivados de acido 1-(2-fluorobifenil-4-il)-alquil carboxilico para la terapia de la amiloidosis transtiretina | |
| AR042362A1 (es) | Derivados de 3h-quinazolin-4-ona, proceso de obtencion y composiciones farmaceuticas que los contienen | |
| AR043430A1 (es) | Derivados de diarilcicloalquilo, procesos para su preparacion y su uso como agentes farmaceuticos | |
| AR043427A1 (es) | Derivados de acido alcanoico sustituidos con aril-cicloalquilo, procedimientos para su obtencion, y su empleo como medicamentos | |
| CR20130476A (es) | Derivados de pirazolidin-3-ona | |
| CY1120953T1 (el) | Παραγωγα 1,3-διυδροϊμιδαζολο-2-θειονης για χρηση στην αγωγη πνευμονικης αρτηριακης υπερτασης και πνευμονικης βλαβης | |
| DOP2010000393A (es) | Derivados de dibenzotiazepina y sus usos | |
| AR063775A1 (es) | 2- imidazoles sustituidos, un proceso para su obtencion y medicamento preparado en base al compuesto | |
| AR064869A1 (es) | Uso e un compuesto de formula i- composicion farmaceutica- metodo de tratamiento | |
| AR055770A1 (es) | Compuestos de piperazina, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
| UA113223C2 (xx) | Арилетинілпіримідини |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |